Anbio Biotechnology Class A Ordinary Shares (NNNN) — Net Asset Momentum
Anbio Biotechnology Class A Ordinary Shares (NNNN) recorded a net asset momentum of 75.4% as of December 2025, with net assets of $30.16 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible net worth ratio of Anbio Biotechnology Class A Ordinary Sha to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Anbio Biotechnology Class A Ordinary Shares Net Asset Momentum (2021–2025)
This chart tracks Anbio Biotechnology Class A Ordinary Shares's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +75.4%, with net assets of $30.16 Million USD as of December 2025. Read NNNN total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
The table below shows the complete annual net asset history for Anbio Biotechnology Class A Ordinary Shares from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Anbio Biotechnology Class A Ordinary Sha market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $30.16 Million | $30.24 Million | $87.84K | ▲ +75.4% |
| 2024 | $17.19 Million | $18.92 Million | $1.73 Million | ▲ +16.0% |
| 2023 | $14.82 Million | $15.81 Million | $993.06K | ▲ +18.1% |
| 2022 | $12.55 Million | $13.96 Million | $1.41 Million | ▲ +394.8% |
| 2021 | $2.54 Million | $4.92 Million | $2.38 Million | — |